<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7045215\results\search\drugs\results.xml">
  <result pre="by HSV2.11 In a cell-culture model, the antiviral medications acyclovir," exact="penciclovir" post="and foscarnet reduced HSV1 particles and Aβ and phosphorylated"/>
  <result pre="zoster and chickenpox.30 No other antiviral drug, including acyclovir (intravenous)," exact="famciclovir" post="and ganciclovir, is superior to valacyclovir in the treatment"/>
  <result pre="the patient will be eligible. Use of cholinesterase inhibitors and" exact="memantine" post="is permitted. Doses of these medications need to be"/>
  <result pre="(other than benzodiazepines prescribed at a dose equivalent of 2 mg" exact="lorazepam" post="daily or higher) and other medications prescribed for medical"/>
  <result pre="valacyclovir as per FDA package insert). Use of benzodiapezines in" exact="lorazepam" post="equivalent doses equal to or greater than 2 mg daily."/>
  <result pre="&amp;lt;60.41 If a patient is receiving a cholinesterase inhibitor and/or" exact="memantine" post="to treat AD, the dose needs to be stable"/>
  <result pre="there is any evidence of randomisation imbalance. Cholinesterase inhibitors and/or" exact="memantine" post="that are permitted during the trial may be related"/>
  <result pre="10.1053/j.ajkd.2012.12.00823312723 40WangLH, SchultzM, WellerS, et al.Pharmacokinetics and safety of multiple-dose" exact="valaciclovir" post="in geriatric volunteers with and without concomitant diuretic therapy."/>
  <result pre="44RogersSL, FarlowMR, DoodyRS, et al.A 24-week, double-blind, placebo-controlled trial of" exact="donepezil" post="in patients with Alzheimer's disease. Neurology1998;50:136–45. 10.1212/WNL.50.1.1369443470 45LinM, GongP,"/>
 </snippets>
</snippetsTree>
